BioPharm International
January 02, 2008
Articles
2008 Supplement
1
The replacement of a IgG ELISA assay with an SPR-based test can shorten the production workflow by one day.
January 02, 2008
Articles
2008 Supplement
1
The recombinant approach lends itself to the production of an inexpensive and effective vaccine at large scale.
January 02, 2008
Articles
2008 Supplement
1
Potential interference with maternally-derived antibodies makes most vaccines less effective in the neonate.
January 02, 2008
Articles
2008 Supplement
1
Human HBV can be grouped into eight genotypes, which differ by at least 8%.
January 02, 2008
Articles
2008 Supplement
1
Microstructured transdermal systems can deliver a vaccine in close proximity to the antigen-presenting cells in the epidermis.